“We can’t re-register the price of this drug. At the moment, we simply can no longer supply it at the same price, this would mean that we are working at a loss,” Natalia Vorona, a representative of the plant said.
The company also stressed that this is in no way connected with politics.
"Our refusal to supply mesatonum to Russia is not a political stance. We want to work with Russia, as any commercial enterprise we want to make profit. And it no longer possible under the previous conditions,” she emphasized.
Let’s get started read our news at facebook messenger > > > Click here for subscribe